Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals. [electronic resource]
Producer: 20070510Description: 1513-25 p. digitalISSN:- 0264-410X
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural
There are no comments on this title.
Log in to your account to post a comment.